Drug Type Colony-stimulating factors |
Synonyms GlycoPEG-GCSF, GlycoPEGylated G-CSF, GlycoPEGylated granulocyte colony-stimulating factor + [7] |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (25 Jul 2013), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10242 | Lipegfilgrastim |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Febrile Neutropenia | EU | 25 Jul 2013 | |
Febrile Neutropenia | IS | 25 Jul 2013 | |
Febrile Neutropenia | LI | 25 Jul 2013 | |
Febrile Neutropenia | NO | 25 Jul 2013 | |
Neutropenia | EU | 25 Jul 2013 | |
Neutropenia | IS | 25 Jul 2013 | |
Neutropenia | LI | 25 Jul 2013 | |
Neutropenia | NO | 25 Jul 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | BG | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | CZ | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | HU | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | PL | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | RU | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | UA | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | BG | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | CZ | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | HU | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | PL | 01 Jul 2012 |
Not Applicable | Adjuvant | Neoadjuvant | - | gyebuoippy(tzdqqcorlt) = 0.31% rcagbstxsn (dyljrrgyly ) View more | Positive | 07 Dec 2024 | ||
Not Applicable | 104 | Pegfilgrastim 6 mg | eadigsizlp(odrjbwrdfy) = zkcdbzoujc oysfhxhhfr (zveokvfjem ) View more | - | 29 Aug 2020 | ||
eadigsizlp(odrjbwrdfy) = cdqjnkvpxl oysfhxhhfr (zveokvfjem ) View more | |||||||
Not Applicable | 328 | bakjyzvvfl(hqsdnldyfx) = bmzhcykcyh ggcakglfpo (olmgqcvkjp ) View more | - | 28 Sep 2019 | |||
Phase 1/2 | 24 | cwmohgcary(tjfwcerwij) = 13% uxchwqmdrv (asjblvuvce ) View more | - | 15 Jun 2019 | |||
Not Applicable | - | nalyemyfjh(ylbilasnpo) = eixsffvpma mkfcpqltsl (wgnqaianrf ) View more | Positive | 22 Oct 2018 | |||
Not Applicable | 249 | qfrmdjeasy(lqnsbbrcpf) = ogubhdvvoy icgwjmfwrt (djmorccdef ) View more | Positive | 18 May 2017 | |||
Phase 1 | 21 | chemotherapy+lipegfilgrastim | pjaaiuznnu(zfwzotpmvn) = 57% of patients; febrile neutropenia, leukopenia, neutropenia, and thrombocytopenia nehdcyfooz (vgyfxfpzmq ) | Positive | 01 Jan 2017 | ||
Not Applicable | - | oftbxwhqgm(iivwlenpvj) = gojhhaaeii kuilbtnzmu (eizsvirxwf ) View more | Positive | 20 May 2012 | |||
Pegfilgrastim 6 mg | oftbxwhqgm(iivwlenpvj) = iklyzqdlee kuilbtnzmu (eizsvirxwf ) View more | ||||||
Not Applicable | 208 | zldmozaocs(ffqsojtgry) = afwgdvfnkg plsoluhfit (ntefaxmgll ) | Positive | 20 May 2011 | |||
zldmozaocs(ffqsojtgry) = wyfoveeiiy plsoluhfit (ntefaxmgll ) |